Journey Medical Corp. (DERM)
3.395
-0.16
(-4.37%)
USD |
NASDAQ |
Nov 20, 10:36
Journey Medical Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -15.00M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | -5.00M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -20.00M |
| December 31, 2021 | -1.20M |
| September 30, 2021 | -8.80M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.20M |
| September 30, 2020 | -1.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Talphera, Inc. | 12.92M |
| Fortress Biotech, Inc. | -0.007M |
| Relmada Therapeutics, Inc. | 6.954M |
| Turn Therapeutics, Inc. | -0.0161M |
| ANI Pharmaceuticals, Inc. | -13.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.437M |
| Cash from Financing (Quarterly) | 0.117M |
| Free Cash Flow | -8.621M |
| Free Cash Flow Per Share (Quarterly) | -0.1224 |
| Free Cash Flow to Equity (Quarterly) | -3.517M |
| Free Cash Flow to Firm (Quarterly) | -2.518M |
| Free Cash Flow Yield | -9.00% |